FacebookTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinRSS Feed

DALLAS and NORCROSS, Ga., Oct. 29—SurgiLance, Inc., announced today its first national agreement with Broadlane Inc., a leader in providing supply chain management services to the healthcare industry.

BroadlaneThe three-year agreement covers the innovative SurgiLance™ One-Step Safety Lancet products designed for micro-blood sampling.

"SurgiLance is pleased to have this opportunity with Broadlane," said Hugh Cooper, Sr. vice president and COO of SurgiLance. "Broadlane's focus on safety and OSHA's current safety initiative combined with end-user input finalized the decision making process.

"We believe our medical product line will help meet our mutual goals of providing access to medical products that are easy to use and cost effective, while addressing the critical safety needs of healthcare workers and patients."

Developed in Singapore and distributed throughout the world, the One-Step Safety Lancet has quickly gained the favor of clinicians. It can be activated quickly and minimizes patient distress.

"In order to get the full benefit from safety needle products, our customers want them to provide the safety they need and, at the same time, be easy to use," said Hank Ffrench, of Broadlane's Contracting Services Department. "Our customers selected the SurgiLance products because it met that criteria."

About Broadlane

Through an extensive suite of services, Broadlane delivers comprehensive supply chain management services to the healthcare industry. Those services include group purchasing, procurement strategy consulting, materials management outsourcing, and technology services. Among the companies that focus on improving efficiencies within the healthcare supply chain, only Broadlane offers this full array of services.

Broadlane customers include leading healthcare providers such as Kaiser Permanente, Tenet Healthcare Corporation (NYSE: THC), Universal Health Services (NYSE: UHS), Continuum Health Partners, Community Health Systems (NYSE: CYH), U.S. Oncology (NasdaqNM: USON), IASIS Healthcare, MedCath Inc. (NasdaqNM: MDTH) and others.

Broadlane has offices in San Francisco and Oakland, California; Dallas; and New York City. For more information visit www.broadlane.com.

Ed. note: This release was published prior to MediPurpose™ changing its name from its prior company name—SurgiLance—in 2006.





Join MediPurpose on FaceBook LinkedIn YouTube Delicious Twitter